Compounded with
Semaglutide
Not verified in the sources we checked.
Tirzepatide
Not verified in the sources we checked.
Product evidence does not establish current availability.
Pharmacy evidence record · researched 2026-08-20
Pharmacy Innovations
Legal identity not verified in the bound record
5 citations1 action records8 explicit unknowns
Locations in the source record
- 2936 W 17th Street, Erie, PA 16505
Services named by sources
- Customized compounded medications
- Nationwide network fulfillment
- Hormone health
- Dermatology
- Pediatrics
- Veterinary medicine
- Weight-loss compounding category
Regulatory compliance
503 pathway evidence
A pathway label describes which federal rules apply — it is not a quality claim.
Section 503A
Source-backed pathway evidence
FDA's action index labels the Erie Pharmacy Innovations operation a 503A facility. Section 503A is statutory and not FDA registration.
Section 503B
Not conclusively established
No exact current FDA-registry row was recovered for the brand or Erie entity; absence is not asserted.
What remains unverified
- Complete legal-entity map for network pharmacies
- Current network license roster
- Exact semaglutide relevance
- Exact tirzepatide relevance
- Founded year
- Current warning-letter closeout status
- Network-wide state-board disciplinary actions
- Categorical absence of any affiliated 503B entity
Telehealth providers
No telehealth-provider relationship is verified in the sources we checked.
Clinic Scout links a provider only when an explicit source names the relationship.
Regulatory history
Actions stay dated and bounded.
FDA exact-name search verified the 2023 warning letter and the FDA action-index 503A classification for Erie. Network-wide and state-board actions were not exhaustively checked.
U.S. Food and Drug Administration · 2023-09-20
Warning Letter
FDA stated that products failed to meet section 503A conditions and that investigators observed serious sterile-production deficiencies.
issuedPatient reviews
Share your experienceNo Clinic Scout patient reviews are published for this pharmacy. Submissions are checked before publication.
What this page verifies for you
5 evidence checks carry a date and a source.
Each line traces to a citation in the source list below — read the exact captured wording before relying on it.
- dated source ledger: 5 first-party/regulator citations with URL, accessed date, and exact supporting quote.
- regulator verified state evidence: 1 regulator-verified state record(s) preserved with field-level provenance.
- regulatory action timeline: 1 dated regulatory/action record(s) with bounded summaries and regulator citations.
- 503 status provenance: 503A/503B fields preserve pathway, source status, and current-versus-historical limits from the bound research.
- transparent unknowns: 8 unresolved field(s) are explicitly named and prevented from rendering as facts.
No superiority claim is made for review volume, ratings, or patient sentiment.
Sources and exact captured wording
- first_party · accessed 2026-08-20
Through our nationwide network of compounding pharmacies, we help patients access high-quality compounded medications backed by expert guidance, personalized care, and a commitment to quality every step of the way.
- fda · accessed 2026-08-20
WARNING LETTER WL # 667414
- fda · accessed 2026-08-20
From November 2, 2022, to November 30, 2022, U.S. Food and Drug Administration (FDA) investigators inspected your facility, Southern Tier Home Infusion, Inc. dba Pharmacy Innovations, located at 2936 West 17th Street, Erie, PA 16505.
- fda · accessed 2026-08-20
Pharmacy Innovations, (see Southern Tier Home Infusion, Inc. ), Erie, PA- 503A Facility
- fda · accessed 2026-08-20
Updated as of 8/18/2026
Questions readers ask
Is Pharmacy Innovations legit?
GLP Clinic Scout does not issue a blanket legitimacy verdict. This research record preserves 5 dated first-party or regulator citation(s), 1 regulatory/action record(s), and 8 explicitly unresolved field(s). Review the cited evidence and current license status before making a decision.